Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -5.29% is 30% above its 5-year average of -7.58%, around the middle of its 5-year range (-10.34%–-1.52%).
As of the fiscal period ended Tuesday, June 30, 2026. 35.11% above its 12-month average of -8.15%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -5.29%.
RETURN ON INVESTED CAPITAL (ROIC)
-5.29%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-8.15%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-7.19%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-7.58%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-3.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-1.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-1.98%
CURRENT VS TTM AVG
+35.11%
CURRENT VS 3Y AVG
+26.51%
CURRENT VS 5Y AVG
+30.30%
CURRENT VS 10Y AVG
-51.51%
CURRENT VS 15Y AVG
-311.35%
CURRENT VS 20Y AVG
-166.73%
SECTOR MEDIAN · HEALTHCARE
8.40%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
-162.93%
vs the sector median at left
NeoGenomics, Inc.
Market Cap
$470.35M
Return on Invested Capital (ROIC)
-5.29%
TTM Avg
-8.15%
3Y Avg
-7.19%
5Y Avg
-7.58%
Market Cap
$459.30M
Return on Invested Capital (ROIC)
8.75%
TTM Avg
20.32%
3Y Avg
26.86%
5Y Avg
29.17%
Market Cap
$389.98M
Return on Invested Capital (ROIC)
-25.26%
TTM Avg
-29.12%
3Y Avg
-26.65%
5Y Avg
-26.65%
Market Cap
$41.24M
Return on Invested Capital (ROIC)
-3699.99%
TTM Avg
-104.88%
3Y Avg
-89.50%
5Y Avg
-74.29%
Market Cap
$1.01B
Return on Invested Capital (ROIC)
-7.32%
TTM Avg
-21.18%
3Y Avg
-91.27%
5Y Avg
-61.58%
Market Cap
$1.71B
Return on Invested Capital (ROIC)
-54.45%
TTM Avg
-54.60%
3Y Avg
-46.39%
5Y Avg
-38.46%
Market Cap
$1.74B
Return on Invested Capital (ROIC)
10.03%
TTM Avg
-6.49%
3Y Avg
-7.14%
5Y Avg
-3.83%
Market Cap
$2.13B
Return on Invested Capital (ROIC)
-49.78%
TTM Avg
-43.13%
3Y Avg
-47.40%
5Y Avg
-42.10%
Market Cap
$2.49B
Return on Invested Capital (ROIC)
-28.96%
TTM Avg
-36.25%
3Y Avg
-29.21%
5Y Avg
-30.95%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeoGenomics, Inc. (NEO) | $470.35M | -5.29% | -8.15% | -7.19% | -7.58% |
| NRC Health (NRC)vs › | $459.30M | 8.75% | 20.32% | 26.86% | 29.17% |
| Shoulder Innovations, Inc. (SI)vs › | $389.98M | -25.26% | -29.12% | -26.65% | -26.65% |
| PDS Biotechnology Corporation (PDSB)vs › | $41.24M | -3699.99% | -104.88% | -89.50% | -74.29% |
| Teladoc Health, Inc. (TDOC)vs › | $1.01B | -7.32% | -21.18% | -91.27% | -61.58% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | -54.45% | -54.60% | -46.39% | -38.46% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | 10.03% | -6.49% | -7.14% | -3.83% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.13B | -49.78% | -43.13% | -47.40% | -42.10% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.49B | -28.96% | -36.25% | -29.21% | -30.95% |
| TransMedics Group, Inc. (TMDX)vs › | $2.72B | 5.87% | 7.96% | -0.22% | -9.17% |
ROIC
-5.3%
ROE
-6.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -5.29% |
| 2026-03-31 | -8.24% |
| 2025-12-31 | -8.90% |
| 2025-09-30 | -9.43% |
| 2025-06-30 | -8.86% |
| 2025-03-31 | -5.87% |
| 2024-12-31 | -5.99% |
| 2024-09-30 | -5.97% |
| 2024-06-30 | -6.13% |
| 2024-03-31 | -6.58% |
| 2023-12-31 | -6.80% |
| 2023-09-30 | -7.29% |
| 2023-06-30 | -8.14% |
| 2023-03-31 | -8.67% |
| 2022-12-31 | -9.55% |
| 2022-09-30 | -10.34% |
| 2022-06-30 | -10.12% |
| 2022-03-31 | -8.88% |
| 2021-12-31 | -6.66% |
| 2021-09-30 | -3.95% |
| 2021-06-30 | -1.52% |
| 2021-03-31 | -1.66% |
| 2020-12-31 | -1.43% |
| 2020-09-30 | -1.91% |
| 2020-06-30 | -2.04% |
| 2020-03-31 | 0.76% |
| 2019-12-31 | 2.00% |
| 2019-09-30 | 1.64% |
| 2019-06-30 | 2.14% |
| 2019-03-31 | 2.15% |
| 2018-12-31 | 1.51% |
| 2018-09-30 | 2.77% |
| 2018-06-30 | 1.77% |
| 2018-03-31 | 1.90% |
| 2017-12-31 | 1.08% |
| 2017-09-30 | -1.31% |
| 2017-06-30 | -0.11% |
| 2017-03-31 | 0.17% |
| 2016-12-31 | 0.92% |
| 2016-09-30 | 0.09% |
| 2016-06-30 | -0.31% |
| 2016-03-31 | -1.01% |
| 2015-12-31 | -1.67% |
| 2015-09-30 | 0.72% |
| 2015-06-30 | 1.05% |
| 2015-03-31 | 1.25% |
| 2014-12-31 | 2.93% |
| 2014-09-30 | 2.71% |
| 2014-06-30 | 9.98% |
| 2014-03-31 | 9.49% |
| 2013-12-31 | 9.89% |
| 2013-09-30 | 8.07% |
| 2013-06-30 | 1.26% |
| 2013-03-31 | 2.54% |
| 2012-12-31 | 5.84% |
| 2012-09-30 | 6.69% |
| 2012-06-30 | 11.46% |
| 2012-03-31 | 6.55% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | -11.79% |
| 2011-06-30 | -23.15% |
| 2011-03-31 | -29.46% |
| 2010-12-31 | -37.39% |
| 2010-09-30 | -43.72% |
| 2010-06-30 | -38.71% |
| 2010-03-31 | -26.85% |
| 2009-12-31 | -12.31% |
| 2009-09-30 | -6.61% |
| 2009-06-30 | -9.21% |
| 2009-03-31 | -10.34% |
| 2006-12-31 | 23.45% |
| 2006-09-30 | 10.08% |
| 2006-06-30 | -4.14% |
| 2006-03-31 | -33.76% |
| 2005-12-31 | -193.12% |
| 2005-09-30 | -139.52% |
| 2005-06-30 | -142.46% |
| 2005-03-31 | -175.34% |
| 2004-09-30 | -96.30% |
| 2004-03-31 | -236.60% |
| 2003-12-31 | -222.30% |
